12
VENTILATION SERVO-i WITH NAVA FREEING THE FULL POTENTIAL OF SYNCHRONY This document is intended to provide information to an international audience outside of the US.

VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

Embed Size (px)

Citation preview

Page 1: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

VENTILATIONSERVO-i WITH NAVAFREEING THE FuLL pOTENTIAL OF SyNcHRONy

This document is intended to provide information to an international audience outside of the US.

Page 2: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

| 2 | SERVO-i with NAVA | Critical Care |

NAVA®: Neurally Adjusted Ventilatory Assist (NAVA) is a

unique approach to mechanical ventilation based on

neural respiratory output, in connection with invasive

and non-invasive NAVA.

The act of taking a breath is controlled by the respiratory

center of the brain, which decides the characteristics of

each breath, timing and size. The respiratory center sends

a signal along the phrenic nerve, excites the diaphragm

muscle cells, leading to muscle contraction and descent

of the diaphragm dome. As a result, the pressure in the

airway drops, causing an inflow of air into the lungs.

With NAVA, the electrical activity of the diaphragm (Edi)

is captured, fed to the ventilator and used to assist the

patient’s breathing in synchrony with and in proportion to

the patients own efforts, regardless of patient category or

size. As the work of the ventilator and the diaphragm is

controlled by the same signal, coupling between the

diaphragm and the SERVO-i® ventilator is synchronized

simultaneously.

SERVO-i WITH NAVApATIENT ANd VENTILATOR AS ONE

Synchrony in invasive NAVA.

1

5

2

3

4

Page 3: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

3 | | Critical Care | SERVO-i with NAVA |

NIV NAVA®: In conventional non-invasive ventilation (NIV)

patient-ventilator asynchrony is common. Scientific studies

suggest that leaks play a major role in generating patient-

ventilator asynchrony and discomfort. In infants and

neonates, conventional NIV may be complicated by leaka-

ge and also because the effort by the infant has been too

weak to be reliably detected by the ventilator’s pressure

and flow triggers.

NIV NAVA is neurally controlled non-invasive ventilation.

NIV NAVA will provide synchronized assist, independent of

conventional pneumatic sensors and leakage associated

with patient interfaces. NIV NAVA manages asynchrony, as

the mode does not rely on a pneumatic signal and is not

affected by auto PEEP. Breath triggering and cycle off are

not affected by leakage, and every patient effort – indepen-

dent of type of interface – is assessed and responded to

equally effectively for all patients from adult to the smallest

neonates.

NAVA and the breathing process

1 The brain's respiratory center sends a signal…

2 …which travels via the phrenic nerve and…

3 …excites the diaphragm.

4 The Edi catheter with the electrodes positioned at

the level of the diaphragm captures the electrical

activity of the diaphragm (Edi).

5 The Edi signal is sent to the SERVO-i® ventilator

which synchronizes the ventilation in proportion

to the patient's own breathing efforts.

Synchrony in NIV NAVA.

Page 4: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

| 4 | SERVO-i with NAVA | Critical Care |

SERVO-i WITH NAVATHE bENEFITS

Synchrony redefined: In NAVA®, the ventilator delivers

assist in proportion to patient demand, and the patient and

ventilator are always in synchrony. This benefits the patient,

as the synchronized respiratory assist enables lower assist

levels, and eliminates the mismatch in pneumatic timing

of inspiration and expiration, avoiding the risk of missed

efforts. NAVA provides a smooth transition to natural

breathing.

Edi – the respiratory vital sign: The Edi signal is a unique

parameter in mechanical ventilation. It can be used as a

diagnostic tool to monitor the electrical activity of the

diaphragm (Edi) in any situation for your patients with

breathing difficulties, in any ventilation mode as well as in

standby after extubation. In all ventilation modes, the Edi

curve and its associated value can provide information on

respiratory drive, volume requirements and the effect of the

ventilatory settings, and can be used to gain indications for

sedation and weaning, as well as continuous insight into the

patient diaphragmatic status. All the trends and changes in

the patient’s respiratory drive are recorded and saved.

decision support for intubation or extubation:

The Edi signal also indicates patient condition. An

increasing Edi may signify increasing weakness or

worsening of the patient condition, as objective criteria

for intubation decisions. As the patient’s condition

improves, the decreasing Edi amplitude and pressure

drop is an indicator to consider weaning and extubation.

decision support for unloading and assist titration:

The Edi signal enables the clinicians to set the assist level

from the ventilator, and to optimize unloading. PEEP titrated

to the lowest Edi amplitude means that work of breathing

is mini mized. As the patient’s condition improves with

NAVA, Edi amplitude decreases, resulting in a reduction in

ventilator-delivered pressure.

Edi – the respiratory vital sign

Synchrony redefined

– delivered assistance matched

to neural demands

decision support for;

– unloading and assist

titration

– intubation or extubation

Page 5: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

5 | | Critical Care | SERVO-i with NAVA |

patient comfort: With NAVA®, the respiratory muscles and

the ventilator are driven by the same signal. The delivered

assistance is matched to neural demands. This synchrony

between patient and ventilator may minimize patient dis-

comfort and agitation, promoting spontaneous breathing,

providing for improved sleep quality and possibly reducing

sedation.

decreasing the patient’s pressure load and risk of over-

assist: With NAVA, the patient’s own respiratory demands

determine the level of assistance. The use of NAVA helps

avoid over- or under-assistance of the patient. In an

increasing number of clinical studies, NAVA has been

associated with lower peak airway pressures, compared

to conventional mechanical ventilation with Pressure

Support.

In neonatal and pediatric intensive care patient populations,

ventilation with NAVA was associated with improved

patient-ventilator synchrony and lower peak airway

pressure when compared with Pressure Support ventilation.

In addition to limiting the risk of overassist, NAVA has been

found to prevent patient-ventilator asynchrony and improve

overall patient-ventilator interaction in adult intensive care

patients. NAVA was also associated with unloading of the

respiratory muscles.

SERVO-i WITH NAVAREdEFINING WHAT’S pOSSIbLE

Improved patient comfort

decreasing the patient’s

pressure load and risk of

overassist

Smooth transition

to natural breathing

Page 6: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

| 6 | SERVO-i with NAVA | Critical Care |

SERVO-i WITH NAVA FREEING THE FuLL pOTENTIAL OF SyNcHRONy

NAVA® – independent of type of interface.

Every patient effort is assessed and responded to

equally effectively for all patients from adult to the

smallest neonates.

Page 7: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

7 | | Critical Care | SERVO-i with NAVA |

SERVO-i WITH NAVA FREEING THE FuLL pOTENTIAL OF SyNcHRONy

Page 8: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

| 8 | SERVO-i with NAVA | Critical Care |

SERVO-i WITH NAVAUNIVERSAL EXPERIENCES

SERVO-i WITH NAVAAN ESTAbLISHEd TREATmENT WORLdWIdE

NAVA® is used in intensive care units in countries all around the world for neonatal,

pediatric and adult patients. Clinical evidence for NAVA has been documented in multiple

clinical studies in scientific peer-reviewed journals, a body of work that continues to grow

exponentially every year.

peer-to-peer forum for sharing NAVA experience

The magazine Critical Care News and its associated website, www.criticalcarenews.com

is a forum hosted by MAQUET Critical Care for intensive care clinicians to share clinical

experience of NAVA. The website is a primary source of user information about NAVA and NIV

NAVA, and contains up-to-date lists of clinical literature reference lists, patient case reports

about the use of NAVA in neonatal, pediatric and adult patients, as well as numerous NAVA

lectures and interviews with intensive care physicians about NAVA.

22 | Critical Care News

Toledo Children’s Hospital in Toledo, Ohio cared for over 4,400 patients in 2007 and is accredited by The

Joint Commission. The institution hosts the largest Level III newborn intensive care unit (NICU) in the

region, with 60 beds in individual units to accommodate the needs of the infant and parents, with over

700 admissions per year.

The newborn intensive care unit implemented Neurally Adjusted Ventilatory Assist – NAVA earlier this

year, and staff members have been gaining experience with NAVA in neonatal patients and newborns

with a variety of different conditions. Critical Care News spoke with Judith Gresky, RN, MSN, CMP,

NICU Director, Diane Howard, RRT, Educational Coordinator and neonatologist Howard Stein, MD

regarding their experience in implementing NAVA and Edi technology and using it on a regular basis.

Clinical experience of NAVA

in 40 neonatal patients

Cindy Zimmel, RN and neonatologist Howard Stein, MD with NAVA neonatal patient

CCnews18_090220.indd 22

09-02-26 13.56.59

Critical Care News | 23

Can you describe the size of

your NICU department, average

number of patients and staff?

Judith Gresky: We have 60 beds, and

100 nurses on staff as well as 50 extra

staff members. We have 700 – 800

admissions per year or about 60 per

month, with an average census of

about 46 per week. We have a labor

and delivery room here, and a transport

team that provides transport to 35-

39% of our patients in a 27 county

area in the northwest corner of Ohio

and southeast corner of Michigan.

The average length of stay for our

patients is about 22-23 days. Gestational

ages range from about 22-23 weeks

at the earliest, to full term, and we

have 8 neonatologists on staff to

provide around the clock care.

Dr Howard Stein: This NICU unit has

been in operation for 32 years, and Dr

Krishnan, our senior partner, started

the unit. We have 8 neonatologists and

we provide in-hospital coverage 24

hours a day. There are also 4 neonatal

nurse practitioners and residents from

pediatrics and family practice programs

who work with us. Our facilities and the

services we provide have developed

and expanded throughout the years. In

our latest facility, which we completed

1 year ago, we quadrupled our space

for babies and families. Most of our

babies now have private rooms and

we also have some twin rooms.

Which types or modes of ventilation

are traditionally used in the NICU?

Diane Howard: Prior to implementing

our SERVO-i ventilators in the fall of 2007,

we had been ventilating our babies with

the VIP Bird. While this ventilator was

state of the art when introduced several

years ago, it lacked the newer modes of

ventilation, such as Pressure Regulated

Volume Control (PRVC) and BiVent. We

have used several of these different

modes of ventilation on our babies but

Synchronized Intermittent Mandatory

Ventilation (SIMV) with Pressure Control

has been most frequently used. We have

used PRVC but have found it diffi cult

due to air leaks around the endotracheal

tubes. Volume Control is utilized mostly

on our post-surgical gastrointestinal

babies, as their bellies become distended

and put pressure on the diaphragm.

BiVent mode works well but is not

as user friendly as SIMV Pressure

Control. Since we have 8 neonatologists

in our NICU, the most common

mode of ventilation is SIMV(PC).

Dr Howard Stein: We have traditionally

used pressure limited ventilation with

SIMV. There is an occasional patient

that needs volume limited ventilation.

We have tried PRVC but this was not

successful due to the large airleaks

associated with using uncuffed

endotracheal tubes. About a year ago we

introduced Bivent but this has been put

on hold as we have learned to use NAVA.

Can you describe the weaning process

you utilize currently, for example

with SIMV and how you determine

appropriate time for extubation?

Diane Howard: Our usual approach

to weaning ventilator parameters is to

initially decrease the pressures per blood

gas and chest x-ray results because

barotrauma is a contributor to chronic

lung disease (CLD). We wean to minimal

pressures without creating atelectasis

and then decrease the rate. If the baby

does not have an increase in work of

breathing and does not have apneic

spells, the endotracheal tube is removed.

Occasionally, a trial of endotracheal

CPAP is ordered and if successful, the

baby is extubated. We do not sedate

our babies signifi cantly in our NICU.

What generally is your extubation

success rate? What is the re-

intubation rate within 48 hours?

Diane Howard: Our re-intubation rate

within 24-48 hours after extubation is

generally low, but with neonates anytime

they acquire an infection or become

more apneic, they can fi nd themselves

back on the ventilator within a week

or two. They are not really considered

extubation failures, but have become

sick again and need ventilatory support.

In our older babies, the rate is low,

while in 23-26 week range, 50-70%

are intubated more than once, fairly

typical for this gestational age.

Judith Gresky, RN, MSN, CMP

and NICU Director at Toledo

Children’s Hospital. Diane Howard, RRT, NPS, Education

Coordinator for Respiratory Therapy

at Toledo Children’s Hospital

CCnews18_090220.indd 23

09-02-26 13.57.00

Theme:Deepening knowledge and experience of new ventilation therapies

PAGE 2

Neonatal and Pediatric Ventilation: Emerging Trends and Challenges A Symposium Summary Report from Akron Children’s Hospital

PAGE 16

Clinical experience of NAVA in 40 neonatal patientsNeonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator and Judith Gresky, RN, NICU Director, Toledo Children’s Hospital

PAGE 22

Research and establishing standards of care and training for neonatal intensive care in ChinaDr Bo Sun, MD, PhD, Head of Laboratory of Pediatric Respiratory and Intensive Care Medicine at Shanghai Children’s Hospital of Fudan University, China

PAGE 32

First impressions of the use of a new Heliox ventilator solution Intensive care physician Dr Ian White of the ICU of St. Peter’s Hospital, Surrey, United Kingdom

PAGE 36

The need for high ventilatory performance in anesthesia – perspectives from two clinicians in anesthesiology Professor Capdevila, The University Hospital (CHU) of Montpellier, France and Professor Lönnqvist, pediatric anesthesiologist at Astrid Lindgren Children´s Hospital at Karolinska University Hospital, Stockholm, Sweden

PAGE 40

PAGE 4

Institutional experience of NAVA in neuro and cardiovascular intensive care patients

Jim Kutsogiannis, MD, Darryl Ewanchuk, RRT, Craig Guenther, MD, Kevin Coghlan, RRT and Julie Mitchell, RRT, of the University of Alberta Hospital in Edmonton, Canada

No. 18

CCnews18_090220.indd 1 09-02-26 13.56.35

Page 9: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

9 | | Critical Care | SERVO-i with NAVA |

SERVO-i WITH NAVAUNIVERSAL EXPERIENCES REFERENcES

Selected publications on the topic of NAVA® and NIV.

1. Campoccia Jalde F, Almadhoob AT, Beck J, Slutsky AS, Dunn MS, Sinderby C. Neurally adjusted ventilatory assist and pressure support ventilation in small species and the impact of instrumental dead space. Neonatology 2009; 97 (3): 279-295.

2. Brander L, Sinderby C, Lecomte F, Leong-Poi H, Bell D, Beck J, Tsoporis JN, Vaschetto R, Schultz MJ, Parker TG, Villar J, Zhang H, Slutsky AS. Neurally adjusted ventilatory assist decreases ventilator-induced lung injury and non-pulmonary organ dysfunction in rabbits with acute lung injury. Intensive Care Med 2009; 16: DOI 10.1007/s00134-009-1632-z.

3. Sinderby C, Beck J. Neurally adjusted ventilatory assist for infants in critical condition: Editorial. Pediatric Health (2009); 3(4): 297-301.

4. Breatnach C, Conlon NP, Stack M, Healy M, O´Hare BP. A prospective crossover comparison of neurally adjusted ventilatory assist and pressure-support ventilation in a pediatric and neonatal intensive care population. Pediatr Crit Care Med 2009; Jul 9. PMID 19593246.

5. Bengtsson JA, Edberg KE. Neurally adjusted ventilatory assist in children: An observational study. Pediatr Crit Care Med 2009; Jul 9. PMID 19593241.

6. Lecomte F, Brander L, Jalde F, Beck J, Qui H, Elie C, Slutsky AS, Brunet F, Sinderby C. Physiological response to increasing levels of neurally adjusted ventilatory assist (NAVA). Respir Physiol Neurobiol 2009; 166(2): 117-124.

7. Hummler H, Schultze A. New and alternative modes of mechanical ventilation in neonates. Semin Fetal Neonatal Med 2009; 14(1): 42-48.

8. Beck J, Reilly M, Grasselli G, Mirabella L, Slutsky AS, Dunn MS, Sinderby C. Patient-ventilator interaction during Neurally Adjusted Ventilatory Assist in Very Low Birth Weight Infants. Pediatr Res 2009; 65(6): 663-668.

9. Brander L, Leong-Poi H, Beck J, Brunet F, Hutchinson SJ, Slutsky AS, Sinderby C. Titration and implementation of neurally adjusted ventilatory assist in critically ill patients. Chest 2009; 35(3): 695-703. Epub 2008 Nov 18.

10. Colombo D, Cammarota G, Bergamaschi V, De Luca M, Della Corte F, Navalesi P. Physiologic response to varying levels of pressure support and neurally adjusted ventilatory assist in patients with acute respiratory failure. Intensive Care Med 2008; 34(11): 2010-8. Epub 2008 Jul 16.

11. Laghi F. NAVA: Brain over machine? Intensive Care Med 2008; 34(11): 1966-1968. Epub 2008 Jul 16.

12. Moerer O, Beck J, Brander L, Costa R, Quintel M, Slutsky AS, Brunet F, Sinderby C. Subject-ventilator synchrony during neural versus pneumati-cally triggered non-invasive helmet ventilation. Intensive Care Med 2008; 34(9): 1615-23. Epub 2008 May 30.

13. Vargas F. Neural trigger and cycling off during helmet pressure support ventilation: the epitome of the perfect patient ventilator interaction? Intensive Care Med 2008; 34(9): 1562-4. Epub 2008 May 30.

14. Sinderby C, Beck J. Neurally Adjusted Ventilatory Assist (NAVA): An Update and Summary of Experiences. Neth J Crit Care 2007; 11(5): 243-252.

15. Beck J, Brander L, Slutsky AS, Reilly MC, Dunn MS, Sinderby C. Non-invasive neurally adjusted ventilatory assist in rabbits with acute lung injury. Intensive Care Med 2008; 34(2): 316-23. Epub 2007 Oct 25.

16. Sinderby C, Navalesi P, Beck J, Skrobik Y, Comtois N, Friberg S, Gottfried SB, Lindstrom L. Neural control of mechanical ventilation in respiratory failure. Nat Med 1999; 5(12): 1433-1436.

For more comprehensive lists of scientific studies on the topics of NAVA and NIV, please refer to www.criticalcarenews.com and select topic under Reference List.

Page 10: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator
Page 11: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

11 | | The Gold Standard | Critical Care | SERVO-i with NAVA |

SERVO-i WITH NAVAEmpOWERING HumAN EFFORTmAQuET – THE GOLd STANdARd

In healthcare, it is a well known fact that the best

interventions are those that interfere least with nature’s

own mechanisms.

The MAQUET philosophy is that technical innovation

must promote and support the body’s natural functions.

The MAQUET mission is to provide clinicians with tools

to amplify the patient’s own recovery efforts.

SERVO-i® is a platform that has been extended with an

interactive ventilation therapy – NAVA®. A unique break-

through in ventilation, NAVA puts the patient’s respiratory

center in direct control of SERVO-i mechanical support,

breath by breath.

MAQUET – The Gold Standard.

Page 12: VENTILATION FREEING THE FuLL pOTENTIAL OF SyNcHRONy · PDF fileFREEING THE FuLL pOTENTIAL OF SyNcHRONy ... Neonatologist Howard Stein MD, Diane Howard, RRT, Educational Coordinator

© M

aque

t C

ritic

al C

are

AB

201

0. A

ll rig

hts

rese

rved

. • M

AQ

UE

T re

serv

es t

he r

ight

to

mod

ify t

he d

esig

n an

d s

pec

ifica

tions

con

tain

ed h

erei

n w

ithou

t p

rior

notic

e. •

Ord

er N

o. M

X-0

616

• P

rinte

d in

Sw

eden

• 0

510

. Rev

.01

Eng

lish.

Maquet Critical Care AB171 54 Solna, SwedenPhone: +46 8 730 73 00www.maquet.com

Please visit our websiteswww.maquet.com/nava www.criticalcarenews.com

The following are registered or pending trademarks of maquet critical care Ab: SERVO-i and NAVA

This document is intended to provide information to an international audience outside of the US.

The product NIV NAVA may be pending regulatory approvals to be marketed in your country. Contact your local Maquet representative for more information.

GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within health-care and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical inter-ventions and intensive care.